Recent studies have shown that GBE restrains estrogen-sensitive breast cancer by inhibiting aromatase and estrogen production (Park et al., 2015, 2016), restrains the proliferation of ER-negative breast cancer cells independently of the ERs (Park et al., 2013; Zhao et al., 2013). The gene discussed is CYP19A1; the disease is breast cancer.